IBDEI15Z ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20545,2)
 ;;=^269680
 ;;^UTILITY(U,$J,358.3,20546,0)
 ;;=707.10^^109^1267^94
 ;;^UTILITY(U,$J,358.3,20546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20546,1,4,0)
 ;;=4^Ulcer of Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,20546,1,5,0)
 ;;=5^707.10
 ;;^UTILITY(U,$J,358.3,20546,2)
 ;;=^322142
 ;;^UTILITY(U,$J,358.3,20547,0)
 ;;=414.01^^109^1267^37
 ;;^UTILITY(U,$J,358.3,20547,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20547,1,4,0)
 ;;=4^Cor Atheroscl Natv C Vsl
 ;;^UTILITY(U,$J,358.3,20547,1,5,0)
 ;;=5^414.01
 ;;^UTILITY(U,$J,358.3,20547,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,20548,0)
 ;;=446.5^^109^1267^47
 ;;^UTILITY(U,$J,358.3,20548,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20548,1,4,0)
 ;;=4^Giant Cell Arteritis
 ;;^UTILITY(U,$J,358.3,20548,1,5,0)
 ;;=5^446.5
 ;;^UTILITY(U,$J,358.3,20548,2)
 ;;=^117658
 ;;^UTILITY(U,$J,358.3,20549,0)
 ;;=446.21^^109^1267^48
 ;;^UTILITY(U,$J,358.3,20549,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20549,1,4,0)
 ;;=4^Goodpasture's Syndrome
 ;;^UTILITY(U,$J,358.3,20549,1,5,0)
 ;;=5^446.21
 ;;^UTILITY(U,$J,358.3,20549,2)
 ;;=^52601
 ;;^UTILITY(U,$J,358.3,20550,0)
 ;;=V58.67^^109^1267^56
 ;;^UTILITY(U,$J,358.3,20550,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20550,1,4,0)
 ;;=4^Long-Term Use of Insulin
 ;;^UTILITY(U,$J,358.3,20550,1,5,0)
 ;;=5^V58.67
 ;;^UTILITY(U,$J,358.3,20550,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,20551,0)
 ;;=446.1^^109^1267^60
 ;;^UTILITY(U,$J,358.3,20551,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20551,1,4,0)
 ;;=4^Mucocutan Lymph Node Syndrome
 ;;^UTILITY(U,$J,358.3,20551,1,5,0)
 ;;=5^446.1
 ;;^UTILITY(U,$J,358.3,20551,2)
 ;;=^79494
 ;;^UTILITY(U,$J,358.3,20552,0)
 ;;=433.30^^109^1267^63
 ;;^UTILITY(U,$J,358.3,20552,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20552,1,4,0)
 ;;=4^Occl/Sten Mult/Bil Art w/o CRB
 ;;^UTILITY(U,$J,358.3,20552,1,5,0)
 ;;=5^433.30
 ;;^UTILITY(U,$J,358.3,20552,2)
 ;;=^295803
 ;;^UTILITY(U,$J,358.3,20553,0)
 ;;=451.83^^109^1267^69
 ;;^UTILITY(U,$J,358.3,20553,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20553,1,4,0)
 ;;=4^Phl/Thrombophl Deep Veins,UEs
 ;;^UTILITY(U,$J,358.3,20553,1,5,0)
 ;;=5^451.83
 ;;^UTILITY(U,$J,358.3,20553,2)
 ;;=^295745
 ;;^UTILITY(U,$J,358.3,20554,0)
 ;;=451.82^^109^1267^70
 ;;^UTILITY(U,$J,358.3,20554,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20554,1,4,0)
 ;;=4^Phl/Thrombophl Sup Veins,UEs
 ;;^UTILITY(U,$J,358.3,20554,1,5,0)
 ;;=5^451.82
 ;;^UTILITY(U,$J,358.3,20554,2)
 ;;=^295744
 ;;^UTILITY(U,$J,358.3,20555,0)
 ;;=451.84^^109^1267^71
 ;;^UTILITY(U,$J,358.3,20555,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20555,1,4,0)
 ;;=4^Phl/Thrombophl,UEs,Unspec
 ;;^UTILITY(U,$J,358.3,20555,1,5,0)
 ;;=5^451.84
 ;;^UTILITY(U,$J,358.3,20555,2)
 ;;=^295746
 ;;^UTILITY(U,$J,358.3,20556,0)
 ;;=446.0^^109^1267^73
 ;;^UTILITY(U,$J,358.3,20556,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20556,1,4,0)
 ;;=4^Polyartertitis Nodosa
 ;;^UTILITY(U,$J,358.3,20556,1,5,0)
 ;;=5^446.0
 ;;^UTILITY(U,$J,358.3,20556,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,20557,0)
 ;;=V81.0^^109^1267^77
 ;;^UTILITY(U,$J,358.3,20557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20557,1,4,0)
 ;;=4^Screen for Ischemic Heart Disease
 ;;^UTILITY(U,$J,358.3,20557,1,5,0)
 ;;=5^V81.0
 ;;^UTILITY(U,$J,358.3,20557,2)
 ;;=^295687
 ;;^UTILITY(U,$J,358.3,20558,0)
 ;;=353.0^^109^1267^84
 ;;^UTILITY(U,$J,358.3,20558,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20558,1,4,0)
 ;;=4^Thoracic Outlet Syndrome
 ;;^UTILITY(U,$J,358.3,20558,1,5,0)
 ;;=5^353.0
 ;;^UTILITY(U,$J,358.3,20558,2)
 ;;=^16605
 ;;^UTILITY(U,$J,358.3,20559,0)
 ;;=451.89^^109^1267^87
 ;;
 ;;$END ROU IBDEI15Z
